Amedica has announced that the 10,000th patient has been implanted with its Valeo interbody fusion device, which is made of Amedica’s proprietary silicon nitride ceramic technology and is used during surgical procedures to treat spinal disorders such as spondylolisthesis.
Grant Skidmore of Neurosurgical Specialists, Norfolk, USA, said: “In my four years of experience with silicon nitride interbody fusion devices, I’ve seen the material exceed the capabilities of poly-ether-ether-ketone (PEEK) and titanium (Ti), resulting in better fusion, which translates to better results for my patients. As a spinal surgeon, my paramount concern is getting my patients back to their daily activities as soon as possible. Patients who I’ve treated with Valeo implants have had a quicker recovery time compared to traditional implants.”
According to a company press release, the Valeo interbody fusion device system includes cervical and lumbar implants designed to participate in the fusion process, optimising patient outcomes. The implants are semi-radiolucent allowing surgeons to ascertain exact placement intraoperatively and improve post-operative monitoring. Valeo interbody fusion devices do not cause MRI or CT artefacts which can make imaging interpretation difficult.